Cognoptix
company
About
Cognoptix develops non-invasive eye tests for the early diagnosis of alzheimer disease.
- 1 - 10
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $2.60M
- Industries
- Biotechnology,Health Care,Health Diagnostics,Medical Device,Therapeutics
- Founded date
- Jan 1, 2001
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Cognoptix is creating and developing an innovative, non-invasive eye test to assist in the early diagnosis of Alzheimer's Disease. Cognoptix's goal is to provide clinicians with a quick, predictive, reliable, inexpensive, and widely available test, enabling early diagnosis and treatment.
The company was founded in 2001 and headquartered in Marlborough, Massachusetts.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$21.60M
Cognoptix has raised a total of
$21.60M
in funding over 2 rounds. Their latest funding was raised on
Sep 28, 2020 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 28, 2020 | Series Unknown | $2.60M | 1 | — | — | Detail |
| Oct 22, 2008 | Series B | $18.50M | 1 | — | — | Detail |
| Jan 23, 2006 | Angel | $500K | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
Cognoptix is funded by 3 investors.
Sidecar Fund2
and Rockport Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series Unknown |
Rockport Venture Partners
|
— | Series B |
Granite State Angels
|
— | Angel |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
